Nisamox 50mg Tablets are for oral administration to dogs and cats - they are round, pink, biconvex tablets with a score line and 50 embossed on opposing faces. Each Nisamox 50 mg tablet contains Amoxicillin 40mg (as amoxicillin trihydrate) and 10mg Clavulanic acid (as Potassium clavulanate) with 0.105mg Carmoisine Lake (E122).
Nisamox 250mg Tablets are for oral administration to dogs - they are round, pink, biconvex tablets with a score line and 250 embossed on opposing faces. Each Nisamox 250mg tablet contains Amoxicillin 200mg (as amoxicillin trihydrate) and 50mg Clavulanic acid (as Potassium clavulanate) with 0.525mg Carmoisine Lake (E122).
The tablets are indicated in the treatment of the following infections caused by β-lactamase producing strains of bacteria sensitive to amoxicillin in combination with clavulanic acid:
Skin infections (including superficial and deep pyodermas) caused by susceptible Staphylococci.
Urinary tract infections caused by susceptible Staphylococci or Escherichia coli.
Respiratory infections caused by susceptible Staphylococci.
Enteritis caused by susceptible Escherichia coli.
It is recommended to carry out suitable tests for sensitivity testing when initiating the treatment. The treatment should only proceed if sensitivity is proven to the combination.
Dosage and administration:
Administration is via the oral route. The dosage rate is 12.5 mg combined actives/kg body weight twice daily. The tablets may be crushed and added to a little food. The following tables are intended as a guide to dispensing the product at the standard dose rate of 12.5 mg of combined actives per kg twice daily.